Oivi
About[edit]
Oivi AS is a Norwegian medical technology company developing smart eye screening solutions. Founded in 2017 with 7 employees, the company focuses on enabling early detection of diabetic retinopathy.
Technology[edit]
Oivi Fundus Camera[edit]
Oivi has developed a system combining:
- Custom-built optics
- Robotics
- Artificial intelligence
- Cloud connectivity
The Oivi camera enables screening for diabetic retinopathy at the point of care — in primary care centres, diabetes clinics, pharmacies, or eye hospitals — rather than requiring referral to a specialist ophthalmologist.
Clinical Need[edit]
- 500 million adults worldwide suffer from diabetes
- Projected 51% increase in diabetes by 2045
- 1 in 3 people with diabetes develop diabetic retinopathy
- Diabetic retinopathy is a leading cause of preventable blindness
- Early detection enables treatment before vision loss occurs
Value Proposition[edit]
- Early detection of diabetic retinopathy reduces preventable blindness
- Point-of-care screening reaches high-risk patients in primary care settings
- Rapid diagnosis shortens time-to-treatment
- Reduces costs for patients and healthcare systems
Market Position[edit]
Oivi competes in the diabetic retinopathy screening market with companies including Remidio, EYENZA, and others. The company's approach using custom-built optics and robotics represents a hardware-intensive approach to AI-based screening.